Ultrafast and selective separation of 99mTc from molybdenum matrix using DBDGA deliberately tailored macrocyclic crown-ethers

Wenya Tai,Junqiang Yang,Fei Wu,Keliang Shi,Yaowen Zhang,Shaodong Zhu,Xiaolin Hou
DOI: https://doi.org/10.1016/j.jhazmat.2022.130437
2023-02-15
Abstract:Technetium-99m (99mTc) is an important medical radionuclide. Due to the crisis in supply of molybdenum-99 (99Mo), production of 99mTc directly via the 100Mo (p, 2 n) reaction by cyclotron was proposed. In this process, the most critical challenge is to rapidly and efficiently separate 99mTc from high concentration of molybdenum. In this work, a novel ligand, bis(N,N-dibutyldiglycolamide)dibenzo-18-crown-6 (BisDBDGA-DB18C6) was successfully synthesized and used for extraction of TcO4- /ReO4- from molybdenum. The results demonstrated that BisDBDGA-DB18C6 expressed excellent selectivity for TcO4- with a high separation factor of 1.6 × 105 against Mo, a fast extraction kinetic (within 45 s), and a high extraction capacity of 211 mmol ReO4- (99TcO4-)/per mole of extractant. The extraction mechanism was proposed as a co-interaction of macrocyclic crown ether and N,N-dibutyldiglycolamide group through slope analysis, FT-IR, ESI-MS, 1H NMR titration and theory calculations. Importantly, 99Tc in the organic phase can be quantitatively (> 99%) and easily back-extracted using deionized water, which can be directly used for medical applications.
What problem does this paper attempt to address?